Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Current Deferred Tax Assets: 2010-2014

Historic Current Deferred Tax Assets for Anika Therapeutics (ANIK) over the last 5 years, with Dec 2014 value amounting to $1.2 million.

  • Anika Therapeutics' Current Deferred Tax Assets rose 113.85% to $1.4 million in Q3 2015 from the same period last year, while for Sep 2015 it was $1.4 million, marking a year-over-year increase of 113.85%. This contributed to the annual value of $1.2 million for FY2014, which is 80.38% up from last year.
  • According to the latest figures from FY2014, Anika Therapeutics' Current Deferred Tax Assets is $1.2 million, which was up 80.38% from $659,040 recorded in FY2013.
  • Anika Therapeutics' 5-year Current Deferred Tax Assets high stood at $2.0 million for FY2012, and its period low was $659,040 during FY2013.
  • For the 3-year period, Anika Therapeutics' Current Deferred Tax Assets averaged around $1.3 million, with its median value being $1.2 million (2014).
  • As far as peak fluctuations go, Anika Therapeutics' Current Deferred Tax Assets plummeted by 67.56% in 2013, and later spiked by 80.38% in 2014.
  • Anika Therapeutics' Current Deferred Tax Assets (Yearly) stood at $2.0 million in 2010, then declined by 3.60% to $1.9 million in 2011, then climbed by 5.87% to $2.0 million in 2012, then crashed by 67.56% to $659,040 in 2013, then surged by 80.38% to $1.2 million in 2014.